Cargando…

Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma

γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHU, JING, JIANG, FENG, NI, HONG-BING, XIAO, MING-BING, CHEN, BU-YOU, NI, WEN-KAI, LU, CUI-HUA, NI, RUN-ZHOU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524245/
https://www.ncbi.nlm.nih.gov/pubmed/23251247
http://dx.doi.org/10.3892/etm.2012.783
_version_ 1782253299100024832
author ZHU, JING
JIANG, FENG
NI, HONG-BING
XIAO, MING-BING
CHEN, BU-YOU
NI, WEN-KAI
LU, CUI-HUA
NI, RUN-ZHOU
author_facet ZHU, JING
JIANG, FENG
NI, HONG-BING
XIAO, MING-BING
CHEN, BU-YOU
NI, WEN-KAI
LU, CUI-HUA
NI, RUN-ZHOU
author_sort ZHU, JING
collection PubMed
description γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The purposes of the present study were to compare the reproducibility and sensitivity between the manual and commercial kit methods and to evaluate the diagnostic efficiency for HCC with the combined analysis of GGT-II, α-L-fucosidase (AFU) and α-fetoprotein (AFP). In patients with various liver diseases (HCC, liver cirrhosis and chronic hepatitis) and normal subjects, GGT-II was detected by manual and commercial polyacrylamide gel electrophoresis (PAGE). The levels of AFU and AFP were assayed by colorimetry and a chemiluminescence immunoassay, respectively. The commercial PAGE had equal diagnostic efficiency with traditional manual PAGE and no significant differences were observed in intra- and average-gel reproducibility and GGT-II sensitivities between the manual and commercial PAGE (P>0.05). The incidence of GGT-II detected by commercial PAGE in HCC patients was 84.1% and <8% in benign liver disease. The levels of AFU and AFP in the benign liver diseases and normal subjects were lower than those in HCC. According to the cut-off value obtained by receiver operating characteristic curves, a total of 56.6 and 59.3% of HCC patients (64 out of 113 and 67 out of 113) had AFU >636.5 μmol/l h and AFP >44.0 μg/l, respectively. There were no significant correlations between GGT-II and AFU or AFP. Combined detection of GGT-II with AFU or AFP increased the diagnostic sensitivity to 92.9 and 93.8%, respectively. These results suggest that commercial PAGE provides a simple and reproducible method for GGT-II detection. Combined determination of GGT-II with AFU or AFP exhibited superior sensitivity and specificity for the diagnosis of HCC.
format Online
Article
Text
id pubmed-3524245
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-35242452012-12-18 Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma ZHU, JING JIANG, FENG NI, HONG-BING XIAO, MING-BING CHEN, BU-YOU NI, WEN-KAI LU, CUI-HUA NI, RUN-ZHOU Exp Ther Med Articles γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The purposes of the present study were to compare the reproducibility and sensitivity between the manual and commercial kit methods and to evaluate the diagnostic efficiency for HCC with the combined analysis of GGT-II, α-L-fucosidase (AFU) and α-fetoprotein (AFP). In patients with various liver diseases (HCC, liver cirrhosis and chronic hepatitis) and normal subjects, GGT-II was detected by manual and commercial polyacrylamide gel electrophoresis (PAGE). The levels of AFU and AFP were assayed by colorimetry and a chemiluminescence immunoassay, respectively. The commercial PAGE had equal diagnostic efficiency with traditional manual PAGE and no significant differences were observed in intra- and average-gel reproducibility and GGT-II sensitivities between the manual and commercial PAGE (P>0.05). The incidence of GGT-II detected by commercial PAGE in HCC patients was 84.1% and <8% in benign liver disease. The levels of AFU and AFP in the benign liver diseases and normal subjects were lower than those in HCC. According to the cut-off value obtained by receiver operating characteristic curves, a total of 56.6 and 59.3% of HCC patients (64 out of 113 and 67 out of 113) had AFU >636.5 μmol/l h and AFP >44.0 μg/l, respectively. There were no significant correlations between GGT-II and AFU or AFP. Combined detection of GGT-II with AFU or AFP increased the diagnostic sensitivity to 92.9 and 93.8%, respectively. These results suggest that commercial PAGE provides a simple and reproducible method for GGT-II detection. Combined determination of GGT-II with AFU or AFP exhibited superior sensitivity and specificity for the diagnosis of HCC. D.A. Spandidos 2013-01 2012-10-31 /pmc/articles/PMC3524245/ /pubmed/23251247 http://dx.doi.org/10.3892/etm.2012.783 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
ZHU, JING
JIANG, FENG
NI, HONG-BING
XIAO, MING-BING
CHEN, BU-YOU
NI, WEN-KAI
LU, CUI-HUA
NI, RUN-ZHOU
Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title_full Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title_fullStr Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title_full_unstemmed Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title_short Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
title_sort combined analysis of serum γ-glutamyl transferase isoenzyme ii, α-l-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524245/
https://www.ncbi.nlm.nih.gov/pubmed/23251247
http://dx.doi.org/10.3892/etm.2012.783
work_keys_str_mv AT zhujing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT jiangfeng combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT nihongbing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT xiaomingbing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT chenbuyou combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT niwenkai combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT lucuihua combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma
AT nirunzhou combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma